Desiccant Regulatory Compliance: REACH DMF Restriction, FDA 21 CFR and Pharmaceutical GMP

Overview #

The compliance gap that creates the most risk when sourcing desiccants from China is not material quality — it is documentation. Most Chinese desiccant suppliers can produce silica gel or molecular sieve that meets the physical specification. What they routinely cannot produce is a complete regulatory compliance package: a REACH-compliant Safety Data Sheet with DMF restriction evidence, an FDA 21 CFR food-contact declaration with lot traceability, and a pharmaceutical GMP batch record that would survive an auditor’s review. Buyers who discover this gap after placing a volume order face quarantine, re-qualification costs, and in regulated industries, potential product recall exposure.

REACH DMF Restriction: What the Regulation Actually Requires for Desiccants #

Dimethyl fumarate (DMF) became a regulated substance under ECHA REACH following widespread contact dermatitis incidents linked to desiccant sachets placed inside furniture and footwear shipments. The restriction — codified under REACH Annex XVII, Entry 61 — prohibits placing articles on the EU market where DMF concentration exceeds 0.1 mg/kg (0.1 ppm by mass) in any part of the article or its packaging. This is not a material specification limit; it is an article-level restriction, which means the desiccant sachet itself, the outer packaging, and any enclosed component must each individually comply.

The practical implication for procurement is significant. A silica gel desiccant that is chemically pure may still fail REACH DMF compliance if the sachet fabric or the outer carton was treated with DMF as an anti-mold agent during storage or transit — a practice that was common in Chinese export logistics before the restriction took effect and still occurs in non-compliant supply chains. In our supplier qualification program, we have seen incoming shipments where the silica gel bead itself tested below 0.1 ppm, but the non-woven sachet fabric tested at 0.4 mg/kg — a clear REACH violation that would have resulted in EU customs seizure.

Test method for DMF content is typically ASTM International or EN 16186 (textile extraction method), with GC-MS confirmation. The detection limit must be demonstrated at or below 0.05 mg/kg to provide adequate margin against the 0.1 mg/kg threshold. Any COA that reports DMF as “not detected” without specifying the method detection limit is not a compliant document — it is a gap that customs authorities and notified bodies will flag immediately.

Buyers sourcing desiccants for EU-destined products — including consumer goods packaging, pharmaceutical secondary packaging, and electronics — must request a third-party DMF test report, not a supplier self-declaration. The test must be performed on the complete article as shipped, not on the raw desiccant material alone.

FDA 21 CFR Compliance: Food Contact and Pharmaceutical Packaging Applications #

For desiccants used in food packaging, nutraceutical containers, or pharmaceutical primary and secondary packaging destined for the US market, the relevant framework is FDA Guidelines under 21 CFR. The specific sections that apply depend on application:

• 21 CFR 182.2727 — Silica gel as a direct food additive (GRAS status, limited to use as an anticaking agent and desiccant in food packaging)
• 21 CFR 175–177 — Indirect food additives covering packaging materials in contact with food
• 21 CFR Part 211 — Current Good Manufacturing Practice for finished pharmaceuticals (cGMP), which governs desiccants used in pharmaceutical packaging

The most common sourcing error we see is buyers requesting “FDA-approved” desiccant and accepting a supplier’s self-declaration letter as sufficient documentation. FDA does not “approve” desiccant materials in the way that a notified body certifies a medical device. What FDA compliance actually means for silica gel desiccants is conformance to the GRAS listing under 21 CFR 182.2727, which requires the material to be food-grade silicon dioxide with no leachable contaminants above specified thresholds. The supplier must be able to provide a Food Contact Compliance Declaration referencing the specific CFR section, supported by extractables and leachables (E&L) testing data.

For pharmaceutical packaging applications, the desiccant must be manufactured under cGMP conditions per 21 CFR Part 211. This means the supplier must maintain batch records, raw material traceability, in-process controls, and release testing documentation. In practice, fewer than 20% of Chinese desiccant suppliers we have evaluated maintain a cGMP-compliant quality system that would pass a US FDA facility inspection. Most can produce a certificate that says “manufactured under GMP conditions” — but when you request the batch record, the deviation log, and the raw material COA chain, the documentation either does not exist or is not in a format that meets 21 CFR Part 211 requirements.

Most Western buyers do not realize that Chinese pharmaceutical desiccant suppliers are typically audited against SAC China Standards GB/T 10455 (silica gel for industrial use) or GB/T 23350 (desiccant for packaging), neither of which is equivalent to FDA 21 CFR Part 211 cGMP. A supplier who is fully compliant with GB/T 23350 may still be non-compliant with FDA requirements — and the English-language documentation they provide will not make this distinction clear.

Pharmaceutical GMP Requirements: Batch Traceability and Qualification Testing #

For pharmaceutical and medical device applications, desiccant compliance goes beyond material specification. The desiccant is classified as a packaging component, and under ICH Q7 (API GMP guideline) and 21 CFR Part 211, packaging components must be qualified, released against specification, and traceable to the finished product batch record.

The minimum qualification package for a pharmaceutical-grade desiccant from a Chinese supplier should include:

Material specification: Silica gel or molecular sieve type, particle size distribution (typically 2–5 mm for canister desiccants, 0.5–1.5 mm for sachet fill), moisture adsorption capacity at 25°C / 75% RH (minimum 25% w/w for Type A silica gel per ISO Standards ISO 10716), and heavy metal content (lead ≤ 5 ppm, arsenic ≤ 1 ppm per USP <231> or equivalent).

Incoming inspection protocol: In our qualification program, we require lot-by-lot moisture adsorption capacity testing and heavy metal screening for pharmaceutical-grade desiccant. The pass threshold for adsorption capacity is ≥ 25% w/w at 25°C/75% RH. Batches that test below 22% w/w are rejected outright; batches between 22–25% trigger a supplier deviation investigation before release.

Extractables and leachables: For desiccants in direct contact with pharmaceutical product (canister desiccants inside HDPE bottles, for example), E&L testing per USP <1663> and <1664> is required. This is the documentation that most Chinese suppliers cannot provide — not because the material is unsafe, but because the testing has never been commissioned. The cost of E&L testing is typically USD 3,000–8,000 per material/container combination, and most small-to-mid-size Chinese desiccant suppliers have not invested in it.

Three out of five Chinese desiccant suppliers we evaluated for a pharmaceutical packaging qualification program could not provide E&L data, and two of those five could not provide a complete batch record chain from raw silica gel source to finished sachet. The trigger for most failures was not the desiccant material itself — it was the sachet non-woven fabric, which had no food-contact or pharmaceutical-grade certification from the fabric supplier.

For buyers sourcing desiccants for pharmaceutical applications, the NSF International certification framework (specifically NSF/ANSI 51 for food equipment materials) provides a useful secondary reference for evaluating supplier quality systems, even though it is not a pharmaceutical-specific standard.

Compliance Comparison: REACH, FDA 21 CFR, and Pharmaceutical GMP #

The difference between GB/T 23350 compliance and FDA 21 CFR Part 211 compliance sounds like a documentation formality. In a pharmaceutical audit, it is a critical finding.

Practical Guidance for Buyers #

When sourcing desiccants from China for regulated applications, the first document to request is not the product COA — it is the supplier’s quality system certificate and the scope of that certificate. A ISO 9001 certificate with a scope limited to “industrial desiccants” does not cover pharmaceutical packaging components. Request the certificate scope statement explicitly.

The sourcing mistake we see most often: buyers accept a supplier’s self-declaration of REACH DMF compliance without requesting the third-party test report. The consequence is EU customs detention, which typically costs more in logistics and re-testing fees than the entire desiccant order value. The 0.1 mg/kg DMF threshold applies to the complete article — sachet fabric included — not just the desiccant fill material.

Before committing to volume order for any regulated application, require the following documentation package: (1) Third-party DMF test report on the complete finished article, with GC-MS method and detection limit stated; (2) Food Contact Compliance Declaration referencing the specific 21 CFR section if US food or pharma market; (3) Batch record sample covering raw material receipt, in-process testing, and finished product release; (4) Adsorption capacity test result per ISO 10716 or equivalent, with the specific lot number tested. Suppliers who cannot provide all four within 10 business days of request are not operating at a compliance level appropriate for regulated supply chains.

For related sealing and packaging component compliance considerations, see Gaskets & Sheet Sealing Materials and Cleanroom Consumables.

Frequently Asked Questions #

Q1: What is the DMF concentration limit for desiccants sold into the EU market?
A: 0.1 mg/kg (0.1 ppm) in any part of the complete article, per REACH Annex XVII Entry 61. The limit applies to the sachet fabric and outer packaging, not just the desiccant fill.

Q2: Is GB/T 23350 compliance sufficient for pharmaceutical packaging desiccants exported to the US?
A: No. GB/T 23350 covers adsorption capacity, particle size, and moisture content — it does not require batch records, raw material traceability, or extractables and leachables data. FDA 21 CFR Part 211 requires all three. A supplier who is fully compliant with SAC China Standards GB/T 23350 may still fail a US FDA packaging component qualification audit on documentation grounds alone.

Q3: What is the most common compliance failure we see in Chinese desiccant supplier qualification?
A: The sachet non-woven fabric. This is where most sourcing decisions go wrong. The desiccant fill material often meets specification — the fabric supplier has no food-contact or pharmaceutical-grade certification, and the desiccant manufacturer has never requested one. The threshold that triggers rejection in our program is any sachet component without a traceable food-contact or pharmaceutical-grade material declaration.

Q4: What test documentation should I require before approving a Chinese desiccant supplier for pharmaceutical packaging?
A: Request the full E&L study report per FDA Guidelines USP <1663> and <1664>, a batch record sample covering at least three consecutive production lots, and a raw material COA chain from the silica gel source supplier. If the supplier cannot provide E&L data, the material cannot be qualified for direct pharmaceutical contact applications regardless of other certifications.

Q5: Does “FDA-approved” on a Chinese supplier’s product sheet mean the desiccant is compliant for pharmaceutical use?
A: No. FDA does not approve desiccant materials. The phrase is meaningless as a compliance claim. What matters is whether the supplier can produce a cGMP-compliant batch record package and E&L data — not what is printed on their product sheet.

Published by sinoraw.com Technical Team | Request a sourcing consultation